About Cangene
Cangene is a company based in Rockville (United States) founded in 1998 was acquired by Emergent BioSolutions in December 2013. Cangene operates in a competitive market with competitors including BeiGene, Moderna, Incyte, ALX Oncology and MorphoSys, among others.
- Headquarter Rockville, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Emergent BioSolutions
(Dec 11, 2013)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Cangene
Detailed funding history for Cangene
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Cangene
Cangene has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Emergent BioSolutions.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Vaccines for viral infections are developed by the company.
|
Locked | Locked | Locked |
Investor details for Cangene
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cangene
Investment portfolio details for Cangene
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Cangene
Detailed financials for Cangene
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cangene Comparisons
Peer comparison for Cangene
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cangene
Cangene operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BeiGene, Moderna, Incyte, ALX Oncology and MorphoSys, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| Locked | Locked | Locked |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| Locked | Locked | Locked |
Small molecules are developed for cancer and skin disease treatments.
|
|
| Locked | Locked | Locked |
ALX Oncology is focused on advancing cancer treatment therapies.
|
|
| Locked | Locked | Locked |
Therapeutic antibodies for cancer and other diseases are developed.
|
|
| Locked | Locked | Locked |
mRNA therapeutics platform is provided for multi-functional treatments.
|
Detailed competitors of Cangene
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cangene
Complete news archive for Cangene
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cangene
Cangene was founded in 1998.
Cangene is headquartered in Rockville, United States. It is registered at Rockville, Maryland, United States.
Cangene was founded in 1998 and focused on biopharmaceuticals, particularly hyperimmunes and biodefense products. Operations included plasma-based antitoxins for anthrax, botulism, and vaccinia, with three items held in the U.S. Strategic National Stockpile. Manufacturing facilities were maintained in Winnipeg and Baltimore, alongside a plasma collection site in Winnipeg. Acquisition by Emergent BioSolutions occurred in 2013, relocating headquarters to Rockville, United States.
Cangene's top competitors include Moderna, BeiGene and Strand Therapeutics.
Cangene has 1 investor. Key investors include Emergent BioSolutions.